VNTVontier Corporation

$32.25-25% 1Y

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap vs its sector.

2 good, 1 neutral
What the price assumes~−2% a year

Priced for a decline (~−2% a year). Little growth is priced in even as revenue fell 1% a year over three years, potential value, or a value trap.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 13.3 vs a 13.2 median over 23 quarters (+1% vs median).

Vs sector (EV/EBIT)10.8×

Sector median 30.5× across 203 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jul 3, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 77% of the market
FCF yieldbetter than 81% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What VNT's price assumes

Vontier Corporation trades at 13.3× earnings against 38.2× for the median Scientific & Technical Instruments name, cheaper than its own group.

13.3

Trailing P/E · Scientific & Technical Instruments median 38.2 · cheaper than the typical name in its group

Price / sales
1.39

Price / sales · today's price, trailing year to Jul 3, 2026

Free cash flow yield
9.0%

Free cash flow yield · Scientific & Technical Instruments median 4.0%

Growth the price implies
−2.2%

Growth the price implies · The price pays for −2.2% free cash flow growth a year for a decade; the business has delivered +1.2% a year over the last three.

Details›
Price / booktoday's price, trailing year to Jul 3, 2026
3.59
EV / EBITtoday's price, trailing year to Jul 3, 2026
10.8
EV / salestoday's price, trailing year to Jul 3, 2026
2.03
Technology median P/E459 names
37.7
Scientific & Technical Instruments median P/E18 names
38.2
Free cash flow, trailing twelve months
$385M
Market capitalisation
$4.28B
3-year revenue growth
−1.4%
3-year free cash flow growth
+1.2%
What the market has paid for these earnings: 23 quarters of its own multiple × $2.42 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$29.69
Its own P/E history, median$31.96
Its own P/E history, upper quartile$34.87
52-week range$27.78 – $43.11
Today$32.25

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.